Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC366

Abrócitíníb eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    10.1.2022
  • Application published:
    15.2.2022
  • Grant published:
    15.1.2025
  • Max expiry date:
    9.12.2036
  • Medicine name:
    Cibinqo
  • Medicine for children:
    No

Timeline

Today
10.1.2022Application
15.2.2022Publication
15.1.2025Registration
9.12.2036Expires

Marketing license

  • IS authorization number:
    EU/1/21/1593/001-005; EU/1/21/1593/006-010; EU/1/21/1593/011-015
  • Date:
    30.12.2021
  • Foreign authorization number:
    EU/1/21/1593
  • Date:
    9.12.2021

Owner

  • Name:
    Pfizer Inc.
  • Address:
    66 Hudson Boulevard East, New York, NY 10001-2192 US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 05.01.2025

Upload documents